Avacta Group

View the org chart displaying its 14 main executives

Most searched biographies at Avacta Group

• Alastair Smith, Chief Executive Officer & Director
• Eliot Forster, Non-Executive Chairman of the Board
• Paul Fry, Non-Executive Director

Popular executive movements at Avacta Group

• Christina Coughlin who is Non-Executive Director, will be promoted to Director and Head of Research and Development on Feb. 1, 2024  (posted on January 21 2024).

Create your alert
to follow the executive moves at Avacta Group.

Avacta Group has 2,276 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Avacta Group

• Location | Avacta Life Sciences Limited
• Location | Avacta Life Sciences Limited
• Website Disclaimer | Avacta Life Sciences Limited
• LG Chem renews license triggering payment to Avacta | Avacta Life Sciences Limited
• Re: Press Speculation | Avacta Life Sciences Limited

Social media about Avacta Group

• Avacta Group on Wikipedia, Google News & Yahoo Finance
• Avacta Group on LinkedIn, Twitter & YouTube

Contact by email its executives including Alastair Smith

Call Avacta Group at +44 844...

View the org chart

Register to receive your alert

Report an error